Caspase-3-Dependent Proteolytic Cleavage of Tau Causes Neurofibrillary Tangles and Results in Cognitive Impairment During Normal Aging
Open accessAbstract
Mouse models of neurodegenerative diseases such as Alzheimer's disease (AD) are important for understanding how pathological signaling cascades change neural circuitry and with time interrupt cognitive function. Here, we introduce a non-genetic preclinical model for aging and show that it exhibits cleaved tau protein, active caspases and neurofibrillary tangles, hallmarks of AD, causing behavioral deficits measuring cognitive impairment. To our knowledge this is the first report of a non-transgenic, non-interventional mouse model displaying structural, functional and molecular aging deficits associated with AD and other tauopathies in humans with potentially high impact on both new basic research into pathogenic mechanisms and new translational research efforts. Tau aggregation is a hallmark of tauopathies, including AD. Recent studies have indicated that cleavage of tau plays an important role in both tau aggregation and disease. In this study we use wild type mice as a model for normal aging and resulting age-related cognitive impairment. We provide evidence that aged mice have increased levels of activated caspases, which significantly correlates with increased levels of truncated tau and formation of neurofibrillary tangles. In addition, cognitive decline was significantly correlated with increased levels of caspase activity and tau truncated by caspase-3. Experimentally induced inhibition of caspases prevented this proteolytic cleavage of tau and the associated formation of neurofibrillary tangles. Our study shows the strength of using a non-transgenic model to study structure, function and molecular mechanisms in aging and age related diseases of the brain.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Tau-421 colocalizes with NFTs in human AD brain, and correlates with NFT formation and cognitive impairment in aged mice.
“Tau-421 colocalizes with NFTs in human AD brain, and correlates with NFT formation and cognitive impairment in aged mice [191, 192, 194].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [194]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676 · see citing works
Caspase Functions in Cell Death and DiseasePreprint
McIlwain, D. R., Berger, T., & Mak, T. W. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008656 · Cited by 2,607 · see citing works
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780 · see citing works
Alzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758 · see citing works
Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,462 · see citing works
Role of tau protein in both physiological and pathological conditions
AVILA, J., LUCAS, J. J., PÉREZ, M., & HERNÁNDEZ, F. (2004) · Physiological Reviews · doi:10.1152/physrev.00024.2003 · Cited by 1,005 · see citing works
Trans-Synaptic Spread of Tau Pathology In Vivo
Liu, L., Drouet, V., Wu, J., Witter, M. P., Small, S. A., Clelland, C. L. T., & Duff, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031302 · Cited by 994 · see citing works
Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
Gamblin, T. C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A. L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630428100 · Cited by 831 · see citing works
Guo, X., Winkler, C. A., Li, J., Guan, L., Tang, M., Liao, J., Deng, H., de Thé, G., Zeng, Y., & O’Brien, S. J. (2014) · BioMed Research International · doi:10.1155/2014/434072 · Cited by 667 · see citing works
Mechanisms of tau-induced neurodegeneration
Iqbal, K., Liu, F., Gong, C.-X., Alonso, A. D. C., & Grundke-Iqbal, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0486-3 · Cited by 628 · see citing works
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology
Rissman, R. A., Poon, W. W., Blurton-Jones, M., Oddo, S., Torp, R., Vitek, M. P., LaFerla, F. M., Rohn, T. T., & Cotman, C. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420640 · Cited by 543 · see citing works
Caspase activation precedes and leads to tangles
de Calignon, A., Fox, L. M., Pitstick, R., Carlson, G. A., Bacskai, B. J., Spires-Jones, T. L., & Hyman, B. T. (2010) · Nature · doi:10.1038/nature08890 · Cited by 517 · see citing works
Novak, M., Kabat, J., & Wischik, C. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05665.x · Cited by 398 · see citing works
Neurons May Live for Decades with Neurofibrillary Tangles
Morsch, R., Simon, W., & Coleman, P. D. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199902000-00008 · Cited by 370 · see citing works
Caspase 3 activation is essential for neuroprotection in preconditioning
McLaughlin, B., Hartnett, K. A., Erhardt, J. A., Legos, J. J., White, R. F., Barone, F. C., & Aizenman, E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0232966100 · Cited by 271 · see citing works
Tau truncation during neurofibrillary tangle evolution in Alzheimer’s disease
Guillozet-Bongaarts, A. L., Garcia-Sierra, F., Reynolds, M. R., Horowitz, P. M., Fu, Y., Wang, T., Cahill, M. E., Bigio, E. H., Berry, R. W., & Binder, L. I. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.019 · Cited by 256 · see citing works
Urbanc, B., Cruz, L., Le, R., Sanders, J., Ashe, K. H., Duff, K., Stanley, H. E., Irizarry, M. C., & Hyman, B. T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222433299 · Cited by 237 · see citing works
Protease signalling in cell death: caspases versus cysteine cathepsins
Turk, B., & Stoka, V. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.05.038 · Cited by 211 · see citing works
Proapoptotic Effects of Tau Cleavage Product Generated by Caspase-3
Chung, C.-W., Song, Y.-H., Kim, I.-K., Yoon, W. J., Ryu, B. R., Jo, D., Woo, H., Kwon, Y.-K., Kim, H., Gwag, B.-J., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0335 · Cited by 211 · see citing works
Transgenic models of Alzheimer’s disease: Learning from animals
Spires‐Jones, T. L., & Hyman, B. T. (2005) · NeuroRx · doi:10.1602/neurorx.2.3.423 · Cited by 209 · see citing works
The Role of Caspase Cleavage of Tau in Alzheimer Disease Neuropathology
Cotman, C. W., Poon, W. W., Rissman, R. A., & Blurton-Jones, M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.104 · Cited by 199 · see citing works
Shared Mechanisms of Neurodegeneration in Alzheimer’s Disease and Parkinson’s Disease
Xie, A., Gao, J., Xu, L., & Meng, D.-M. (2014) · BioMed Research International · doi:10.1155/2014/648740 · Cited by 196 · see citing works
Kuranaga, E., & Miura, M. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.01.001 · Cited by 183 · see citing works
Caspase-cleaved Tau Expression Induces Mitochondrial Dysfunction in Immortalized Cortical Neurons
Quintanilla, R. A., Matthews-Roberson, T. A., Dolan, P. J., & Johnson, G. V. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808908200 · Cited by 170 · see citing works
Bussière, T., Bard, F., Barbour, R., Grajeda, H., Guido, T., Khan, K., Schenk, D., Games, D., Seubert, P. A., & Buttini, M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63360-3 · Cited by 169 · see citing works
Basurto‐Islas, G., Luna‐Muñoz, J., Guillozet-Bongaarts, A. L., Binder, L. I., Mena, R., & García‐Sierra, F. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31817275c7 · Cited by 150 · see citing works
Sun, A.-Y., Nguyen, X. V., & Bing, G. (2002) · Journal of Histochemistry and Cytochemistry · doi:10.1177/002215540205000403 · Cited by 146 · see citing works
Spires-Jones, T. L., de Calignon, A., Matsui, T., Zehr, C., Pitstick, R., Wu, H.-Y., Osetek, J. D., Jones, P. B., Bacskai, B. J., Feany, M. B., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3072-08.2008 · Cited by 137 · see citing works
Truncated tau and Aβ cooperatively impair mitochondria in primary neurons
Quintanilla, R. A., Dolan, P. J., Jin, Y. N., & Johnson, G. V. W. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.007 · Cited by 136 · see citing works
Tau as a Biomarker of Neurodegenerative Diseases
Schraen‐Maschke, S., Sergeant, N., Dhaenens, C., Bombois, S., Deramecourt, V., Caillet‐Boudin, M., Pasquier, F., Maurage, C., Sablonnière, B., Vanmechelen, E., et al. (2008) · Biomarkers in Medicine · doi:10.2217/17520363.2.4.363 · Cited by 121 · see citing works
Analysis of Tau Phosphorylation and Truncation in a Mouse Model of Human Tauopathy
Delobel, P., Lavenir, I., Fraser, G. M., Ingram, E., Holzer, M., Ghetti, B. F., Spillantini, M. G., Crowther, R. A., & Goedert, M. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070627 · Cited by 120 · see citing works
Ding, H., Matthews, T. A., & Johnson, G. V. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511697200 · Cited by 114 · see citing works
Apoptosis and in vitro Alzheimer’s disease neuronal models
Calissano, P., Matrone, C., & Amadoro, G. (2009) · Communicative & Integrative Biology · doi:10.4161/cib.7704 · Cited by 111 · see citing works
Santa‐María, I., Hernández, F., Rio, J. D., Moreno, F. J., & Ávila, J. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-17 · Cited by 85 · see citing works
de Calignon, A., Spires-Jones, T. L., Pitstick, R., Carlson, G. A., & Hyman, B. T. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a9fc66 · Cited by 81 · see citing works
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Ly, P. T. T., Cai, F., & Song, W. (2011) · Journal of Visualized Experiments · doi:10.3791/2831 · Cited by 63 · see citing works
Tau cleavage and tau aggregation in neurodegenerative disease
Hanger, D. P., & Wray, S. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381016 · Cited by 60 · see citing works
Proteolytic Cleavage of Polymeric Tau Protein by Caspase-3: Implications for Alzheimer Disease
Jarero-Basulto, J. J., Luna‐Muñoz, J., Mena, R., Krištofíková, Z., Řı́pová, D., Perry, G. L., Binder, L. I., & García‐Sierra, F. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000013 · Cited by 53 · see citing works
Post-translational modifications of tau protein
Pevalova, M., Filipčík, P., Novák, M., Ávila, J., & Iqbal, K. (2006) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03656852 · Cited by 52 · see citing works
Means, J. C., Venkatesan, A., Gerdes, B. C., Fan, J.-Y., Bjes, E. S., & Price, J. L. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005171 · Cited by 48 · see citing works
Self-citationCaspase activation in the Alzheimer's disease brain: Tortuous and torturous
Rohn, T. T., Rissman, R. A., Head, E., & Cotman, C. W. (2002) · Drug News & Perspectives · doi:10.1358/dnp.2002.15.9.740233 · Cited by 48 · cited 1× · see citing works
“There is evidence for increased caspase activation in AD brain [38].”
Tau Alternative Splicing and Frontotemporal Dementia
Kar, A. N., Kuo, D. C., He, R.-Q., Zhou, J., & Wu, J. Y. (2005) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000183082.76820.81 · Cited by 41 · see citing works
Matthews-Roberson, T. A., Quintanilla, R. A., Ding, H., & Johnson, G. V. W. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.111 · Cited by 36 · see citing works
Profiling psychomotor and cognitive aging in four-way cross mice
Sumien, N., Sims, M. N., Taylor, H., & Forster, M. J. (2006) · AGE · doi:10.1007/s11357-006-9015-7 · Cited by 32 · see citing works
Self-citationA Tangled Web – Tau and Sporadic Parkinson's Disease
Wray, S., & Lewis, P. A. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00150 · Cited by 31 · see citing works
Homer-1a immediate early gene expression correlates with better cognitive performance in aging
Kaja, S., Sumien, N., Borden, P. K., Khullar, N., Iqbal, M., Collins, J. L., Forster, M. J., & Koulen, P. (2012) · AGE · doi:10.1007/s11357-012-9479-6 · Cited by 28 · see citing works
Self-citationPro-apoptotic effects of tau mutations in chromosome 17 frontotemporal dementia and parkinsonism
Furukawa, K., D’Souza, I., Crudder, C. H., Onodera, H., Itoyama, Y., Poorkaj, P., Bird, T. D., & Schellenberg, G. D. (2000) · Neuroreport · doi:10.1097/00001756-200001170-00011 · Cited by 28 · see citing works
Kaja, S., Sumien, N., Shah, V. V., Puthawala, I., Maynard, A. N., Khullar, N., Payne, A. J., Forster, M. J., & Koulen, P. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8877-4 · Cited by 26 · see citing works
Self-citationRole of caspase‐3 in tau truncation at D421 is restricted in transgenic mouse models for tauopathies
Zhang, Q., Zhang, X., Chen, J., Miao, Y., & Sun, A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05959.x · Cited by 21 · see citing works
Zorniak, M. (2008) · Eukaryon · Cited by 1 · see citing works
Flagged first, then by citations
1 of the 51 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994 · see citing works
Roles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003 · see citing works
Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers
Quinn, J. P., Corbett, N. J., Kellett, K. A. B., & Hooper, N. M. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-170959 · Cited by 170 · see citing works
Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia
Eshraghi, M., Adlimoghaddam, A., Mahmoodzadeh, A., Sharifzad, F., Yasavoli-Sharahi, H., Lorzadeh, S., Albensi, B. C., & Ghavami, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073330 · Cited by 158 · see citing works
Aggregation of Disordered Proteins Associated with Neurodegeneration
Tsoi, P. S., Quan, M. D., Ferreon, J. C., & Ferreon, A. C. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043380 · Cited by 97 · see citing works
Brandt, R., Trushina, N. I., & Bakota, L. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.590059 · Cited by 88 · see citing works
Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer’s Disease
Pérez, M. J., Vergara-Pulgar, K., Jara, C., Cabezas-Opazo, F., & Quintanilla, R. A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0385-x · Cited by 81 · see citing works
Caspases in Alzheimer’s Disease: Mechanism of Activation, Role, and Potential Treatment
Wójcik, P., Jastrzębski, M. K., Zięba, A., Matosiuk, D., & Kaczor, A. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03847-1 · Cited by 72 · see citing works
Thingore, C., Kshirsagar, V. V., & Juvekar, A. R. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00629-9 · Cited by 60 · see citing works
Conze, C., Rierola, M., Trushina, N. I., Peters, M., Janning, D., Holzer, M., Heinisch, J. J., Arendt, T., Bakota, L., & Brandt, R. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01538-2 · Cited by 50 · see citing works
The “mitochondrial stress responses”: the “Dr. Jekyll and Mr. Hyde” of neuronal disorders
Rimessi, A., Patergnani, S., Morciano, G., Carinci, M., Leo, S., & Pinton, P. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.339473 · Cited by 39 · see citing works
Exosome-mediated delivery of superoxide dismutase for anti-aging studies in Caenorhabditis elegans
Shao, X., Zhang, M., Chen, Y., Sun, S., Yang, S., & Li, Q. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123090 · Cited by 38 · see citing works
Knockout of p75 neurotrophin receptor attenuates the hyperphosphorylation of Tau in pR5 mouse model
Manucat-Tan, N. B., Shen, L.-L., Bobrovskaya, L., Al‐Hawwas, M., Zhou, F. H., Wang, Y., & Zhou, X. (2019) · Aging · doi:10.18632/aging.102202 · Cited by 36 · see citing works
Yang, T., Tran, K. C., Zeng, A. Y., Massa, S. M., & Longo, F. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-77210-y · Cited by 39 · see citing works
Alzheimer’s disease: phenotypic approaches using disease models and the targeting of tau protein
Lauretti, E., & Praticò, D. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1737012 · Cited by 32 · see citing works
Li, W., Li, H., Wang, J., Liu, R., & Wang, X. (2024) · Cell & Bioscience · doi:10.1186/s13578-023-01189-y · Cited by 30 · see citing works
Means, J. C., Gerdes, B. C., & Koulen, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071521 · Cited by 28 · see citing works
Self-citationEllis, M. J., Lekka, C., Holden, K. L., Tulmin, H., Seedat, F., O'Brien, D. P., Dhayal, S., Zeissler, M., Knudsen, J. G., Kessler, B. M., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02729-7 · Cited by 26 · see citing works
Olesen, M. A., Pradenas, E., Villavicencio-Tejo, F., Porter, G. A., Johnson, G. V. W., & Quintanilla, R. A. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.03.017 · Cited by 24 · see citing works
Biundo, F., d’Abramo, C., Tambini, M. D., Zhang, H., Prete, D. D., Vitale, F., Giliberto, L., Arancio, O., & D'adamio, L. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.165 · Cited by 24 · see citing works
Cyclosporine A (CsA) prevents synaptic impairment caused by truncated tau by caspase-3
Tapia-Monsalves, C., Olesen, M. A., Villavicencio-Tejo, F., & Quintanilla, R. A. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103861 · Cited by 24 · see citing works
Olesen, M. A., & Quintanilla, R. A. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03434-4 · Cited by 22 · see citing works
Mani, V., & Alshammeri, B. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411525 · Cited by 22 · see citing works
Activity-dependent tau cleavage by caspase-3 promotes neuronal dysfunction and synaptotoxicity
Opland, C. K., Bryan, M. R., Harris, B., McGillion-Moore, J., Tian, X., Chen, Y., Itano, M. S., Diering, G. H., Meeker, R. B., & Cohen, T. J. (2023) · iScience · doi:10.1016/j.isci.2023.106905 · Cited by 21 · see citing works
Arunsak, B., Pratchayasakul, W., Amput, P., Chattipakorn, K., Tosukhowong, T., Kerdphoo, S., Jaiwongkum, T., Thonusin, C., Palee, S., Chattipakorn, N., et al. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108470 · Cited by 19 · see citing works
Renema, P., Kozhukhar, N., Pastukh, V. V., Spadafora, D., Paudel, S. S., Tambe, D. T., ALEXEYEV, M. F., Frank, D. W., & Stevens, T. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00508.2019 · Cited by 17 · see citing works
Chi, H., Lee, S., Shiu, R.-H., Han, R., Hsieh, C.-P., Wei, T.-M., Lo, C., Chang, H.-Y., & Sang, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-70423-1 · Cited by 17 · see citing works
Hu, Y., Zhou, K., Wang, Z., Yang, L., & Yin, M. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.05.009 · Cited by 15 · see citing works
Criado‐Marrero, M., Gebru, N. T., Gould, L. A., Blazier, D. M., Vidal-Aguiar, Y., Smith, T. M., Abdelmaboud, S. S., Shelton, L. B., Wang, X., Dahrendorff, J., et al. (2021) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-021-00062-x · Cited by 14 · see citing works
Jeong, J., Kim, D. K., Chung, S., Han, J. W., Han, J., & Mook‐Jung, I. (2024) · Aging Cell · doi:10.1111/acel.14420 · Cited by 14 · see citing works
Gozes, I., & Shazman, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.867442 · Cited by 13 · see citing works
Cao, Y., Cao, S., Ge, R., Bao, H., Mou, Y., & Ji, W. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1268230 · Cited by 11 · see citing works
Rizzi, L., & Grinberg, L. T. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01744-9 · Cited by 11 · see citing works
Validation of Tau Antibodies for Use in Western Blotting and ImmunohistochemistryPreprint
Ellis, M. J., Lekka, C., Tulmin, H., O'Brien, D. P., Dhayal, S., Zeissler, M., Knudsen, J. G., Kessler, B. M., Morgan, N. G., Todd, J. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.13.536711 · Cited by 12 · see citing works
Protein Aggregation and Self Assembly in Health and Disease
Basak, A., & Basak, S. (2021) · Current Proteomics · doi:10.2174/1570164618666210223160742 · Cited by 7 · see citing works
Nagaraju, P. G., Ashwini, S., & G., P. P. C. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2092446 · Cited by 7 · see citing works
Olesen, M. A., Villavicencio-Tejo, F., Johnson, G. V. W., Porter, G. A., Jr., & Quintanilla, R. A. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.02.035 · Cited by 6 · see citing works
Amla Therapy as a Potential Modulator of Alzheimer’s Disease Risk Factors and Physiological Change
Teimouri, E., Rainey‐Smith, S. R., Bharadwaj, P., Verdile, G., & Martins, R. N. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191033 · Cited by 6 · see citing works
Villavicencio-Tejo, F., Olesen, M. A., Ampuero, E., & Quintanilla, R. A. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.105991 · Cited by 5 · see citing works
Binsuwaidan, R., Negm, W. A., Elekhnawy, E., Attallah, N. G. M., Ahmed, E., Magdeldin, S., Moglad, E. H. O., Mostafa, S. A., & El-Sherbeni, S. A. (2023) · Pharmaceuticals · doi:10.3390/ph16030398 · Cited by 5 · see citing works
Potential role of Drug Repositioning Strategy (DRS) for management of tauopathy
Zaki, M. O., Elsherbiny, D. A., Salama, M., & Azab, S. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120267 · Cited by 5 · see citing works
Tau and Alzheimer’s Disease: Molecular Mechanisms and Treatment Approaches
Reiss, A. B., Muhieddine, D., Leon, A. Z. D., Voloshyna, I., Gomolin, I. H., & Pinkhasov, A. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-01092-y · Cited by 4 · see citing works
Chi, H., Sang, T., & Chang, H.-Y. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73198 · Cited by 4 · see citing works
Unconventional secretion of tau by VAMP8 impacts its intra- and extracellular cleavage
Pilliod, J., Gélinas-Faucher, M., & Leclerc, N. M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.912118 · Cited by 4 · see citing works
Sillau, S., Coughlan, C. M., Ahmed, M. M., Nair, K. V., Araya, P., Galbraith, M. D., Bettcher, B. M., Espinosa, J. M., Chial, H. J., Epperson, N., et al. (2024) · medRxiv · doi:10.1101/2024.07.14.24310223 · Cited by 4 · see citing works
Is tau pathology a relevant factor in neuronal damage induced by alcohol and other drugs?
Olesen, M. A., Ancía, A., & Quintanilla, R. A. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168059 · Cited by 3 · see citing works
Sillau, S., Coughlan, C. M., Ahmed, M. M., Nair, K. V., Araya, P., Galbraith, M. D., Ritchie, A. M., Wang, A. C., Elos, M. T., Bettcher, B. M., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102525 · Cited by 3 · see citing works
Taheri, M., Moradi, M. H., Koraee, Y., Moghadam, F. H., Nedaei, S. E., Veisi, M., & Ghafouri, H. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.10.054 · Cited by 3 · see citing works
Neuroprotective Effects of the Multitarget Agent AVCRI104P3 in Brain of Middle-Aged Mice
Relat, J., Come, J. A. A. D. S. S., Pérez, B., Camps, P., Muñoz‐Torrero, D., Badı́a, A., Giménez‐Llort, L., & Clos, M. V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092615 · Cited by 3 · see citing works
Alharbi, K. S., Alenezi, S. K., Alsahli, T. G., Alqahtani, R. A., Afzal, M., Kazmi, I. A., & Sayyed, N. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.12.048 · Cited by 1 · see citing works
Mechanosensitive apoptosis in Alzheimer’s disease
Sapozhnikov, G., Ranganathan, R., Wang, S., & Song, Y. (2025) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2025.02 · Cited by 1 · see citing works
Rôle central des glucocorticoïdes et de leurs récepteurs dans l’étiologie de la Maladie d’Alzheimer
Canet, G. (2020) · theses.fr (ABES) · doi:10.70675/c46cedbczd8bbz4a8eza301z82de5785048c
Neuroinflammation- molecular target based therapeutic approach
Paul, D. (2026) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2026.04.006
Dooka, B. D., Orish, C. N., Ezejiofor, A. N., Ugwu, T., Nkpaa, K. W., Okereke, I., Ćirović, A., Ćirović, A., & Orisakwe, O. E. (2026) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2026.127908
- Authors
- Means, J. C., Gerdes, B. C., Kaja, S., Sumien, N., Payne, A. J., Stark, D. A., Borden, P. K., Price, J. L., & Koulen, P.
- Affiliations
- University of Missouri–Kansas City (US)
- Loyola University Chicago (US)
- University of North Texas Health Science Center (US)
- Corresponding author
- Koulen, Peter
- Venue
- Neurochemical Research
- Published
- 2016-05-25
- Volume
- 41
- Issue
- 9
- Pages
- 2278-2288
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- PMC
- PMC4965284
- OpenAlex
- W2395424197
- Cited by
- 54
- References
- 51
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 7 · 2023: 10 · 2022: 5 · 2021: 5 · 2020: 10 · 2019: 2 · 2018: 2 · 2017: 5
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurochemical Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (AG022550, AG027956, AG010485)
- National Center for Research Resources (RR022570, RR027093)
- National Eye Institute (EY022774)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- caspase-3, tau protein, proteolytic cleavage, neurofibrillary tangles, cognitive impairment, normal aging, Alzheimer's disease, tauopathy, caspase inhibition, age-related cognitive decline
- MeSH terms
- Aging, Alzheimer Disease, Animals, Brain, Cognition, Disease Models, Animal, Male, Memory Disorders, Mice, Inbred C57BL, Mice, Transgenic, Neurofibrillary Tangles, tau Proteins, Caspase 3, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review